1 Huge New Reason to Buy Eli Lilly or Novo Nordisk Stock Right Now and Hold It Forever

One key disease-prevention market is drawing closer to being within reach. As if there weren't enough reasons to buy shares of the cardiometabolic drug juggernauts Eli Lilly (LLY 0.32%) and Novo Nordisk (NVO -0.90%), there's now one more big reason to expect these two stocks to keep climbing. While this new opportunity will take some time to cook before it's ready to delight shareholders, one of the two companies is making significant headway, so it won't be much longer in the grand scheme of things. Here's ...